What is the official website of NewAmsterdam Pharma Corporation ?

The official website of NewAmsterdam Pharma Corporation is https://www.newamsterdampharma.com.

What is NewAmsterdam Pharma Corporation's cybersecurity risk score?

NewAmsterdam Pharma Corporation has an AI-generated cybersecurity risk score of 768 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has NewAmsterdam Pharma Corporation experienced?

According to Rankiteo, NewAmsterdam Pharma Corporation currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has NewAmsterdam Pharma Corporation been affected by any supply chain cyber incidents ?

According to Rankiteo, NewAmsterdam Pharma Corporation has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does NewAmsterdam Pharma Corporation have SOC 2 Type 1 certification ?

According to Rankiteo, NewAmsterdam Pharma Corporation is not certified under SOC 2 Type 1.

Does NewAmsterdam Pharma Corporation have SOC 2 Type 2 certification ?

According to Rankiteo, NewAmsterdam Pharma Corporation does not hold a SOC 2 Type 2 certification.

Does NewAmsterdam Pharma Corporation comply with GDPR ?

According to Rankiteo, NewAmsterdam Pharma Corporation is not listed as GDPR compliant.

Does NewAmsterdam Pharma Corporation have PCI DSS certification ?

According to Rankiteo, NewAmsterdam Pharma Corporation does not currently maintain PCI DSS compliance.

Does NewAmsterdam Pharma Corporation comply with HIPAA ?

According to Rankiteo, NewAmsterdam Pharma Corporation is not compliant with HIPAA regulations.

Does NewAmsterdam Pharma Corporation have ISO 27001 certification ?

According to Rankiteo,NewAmsterdam Pharma Corporation is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does NewAmsterdam Pharma Corporation operate in ?

NewAmsterdam Pharma Corporation operates primarily in the Biotechnology industry.

How many employees does NewAmsterdam Pharma Corporation have ?

NewAmsterdam Pharma Corporation employs approximately 81 people worldwide.

Does NewAmsterdam Pharma Corporation own any subsidiaries ?

NewAmsterdam Pharma Corporation presently has no subsidiaries across any sectors.

How many LinkedIn followers does NewAmsterdam Pharma Corporation have ?

NewAmsterdam Pharma Corporation's official LinkedIn profile has approximately 19,541 followers.

Does NewAmsterdam Pharma Corporation have a Crunchbase profile ?

No, NewAmsterdam Pharma Corporation does not have a profile on Crunchbase.

Does NewAmsterdam Pharma Corporation have a LinkedIn profile ?

Yes, NewAmsterdam Pharma Corporation maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/new-amsterdam-pharma-corporation.

How many cybersecurity incidents has NewAmsterdam Pharma Corporation experienced ?

As of July 2, 2026, Rankiteo reports that NewAmsterdam Pharma Corporation has not experienced any cybersecurity incidents.

How many peer or competitor companies does NewAmsterdam Pharma Corporation have ?

NewAmsterdam Pharma Corporation has an estimated 1,072 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

NPC

Boost Score +25 with badge (5 left)

768

/1000

Fair

793

/1000

Fair

NewAmsterdam Pharma Corporation Vendor Cyber Rating & Cyber Score

newamsterdampharma.com

Add Your Compliance Badge

This page is intended for US audiences. Founded in 2019, NewAmsterdam Pharma Corporation is a late-stage clinical biopharmaceutical company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies have been unsuccessful or are not tolerated. The Company is investigating a selective cholesteryl ester transfer protein (CETP) inhibitor as an LDL-C lowering therapy for patients who cannot be treated optimally with currently available lipid-lowering therapy or for patients with Atherosclerotic Cardiovascular Disease/Familial Hypercholesterolemia (ASCVD/FH) on maximally tolerated statin therapy.

NPC A.I CyberSecurity Scoring

Scoring History

NPC

NewAmsterdam Pharma Corporation CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

NPC Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for NPC

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for NewAmsterdam Pharma Corporation in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for NewAmsterdam Pharma Corporation in 2026.

Incident Types NPC vs Biotechnology Industry Avg (This Year)

No incidents recorded for NewAmsterdam Pharma Corporation in 2026.

Incident History - NPC (X = Date, Y = Severity)

Loading…

SUBSIDIARY

NewAmsterdam Pharma Corporation Subsidiaries

Parent Company

NPC

Biotechnology

Website: https://www.newamsterdampharma.com

Company Size: 81

No subsidiary data available for this company.

Loading…

NewAmsterdam Pharma Corporation Similar Companies

Regeneron

cb regeneron.com

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.

Loading…

NEWS

NewAmsterdam Pharma Corporation CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 06, 2026 08:00 AM

NewAmsterdam Pharma Company N.V. (NAMS) Shares Spiked by 57% in Q3

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2025...

Read Article

November 05, 2025 08:00 AM

NewAmsterdam Pharma Company N.V. (NAMS) Reports Q3 Loss, Lags Revenue Estimates

NewAmsterdam Pharma Company N.V. (NAMS) delivered earnings and revenue surprises of -7.89% and -91.03%, respectively, for the quarter ended...

Read Article

October 07, 2025 07:00 AM

NewAmsterdam Pharma Company N.V. (NAMS) Soars 5.9%: Is Further Upside Left in the Stock?

NewAmsterdam Pharma Company N.V. (NAMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings...

Read Article

January 15, 2021 08:00 AM

Forget A.I., cybersecurity is the new buzzword

2021 is all about cybersecurity (but many dealmakers don't expect a rise in valuations)

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-55790

SUMMARY

Craft CMS is a content management system (CMS). In versions 5.0.0-RC1 through 5.9.22 and 4.0.0-RC1 through 4.17.15, an attacker with only a GitHub account can plant a JavaScript payload in a craftcms/cms issue title. When a Craft admin uses the CraftSupport widget’s "Give feedback" screen and types a search term that returns the poisoned issue, the payload executes in the admin’s control panel session. No control panel account or elevated privileges are required on the attacker’s side. This issue has been fixed in versions 4.17.16 and 5.9.23.

Published

Date2026-07-01

Updated

Date2026-07-01

RISK INFORMATION (Score: )

cvss4

Base Score: 7.4

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:A/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-50284

SUMMARY

Craft CMS is a content management system (CMS). In versions 5.0.0-RC1 through 5.9.21 and 4.0.0-RC1 through 4.17.14, theAssetsController::actionDeleteFolder() only requires the deleteAssets:<volume-uid> permission for the target folder. It never enforces deletePeerAssets:<volume-uid>, even though Assets::deleteFoldersByIds() cascades deletion to every descendant folder and every asset inside, regardless of the uploader's assigned privileges. A low-privilege user who has been granted folder-management rights on a shared volume can therefore destroy assets uploaded by other users (peer assets), bypassing the per-asset peer-permission check that the sibling actionDeleteAsset endpoint correctly applies. This issue has been fixed in versions 4.17.15 and 5.9.22.

Published

Date2026-07-01

Updated

Date2026-07-01

RISK INFORMATION (Score: )

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-50283

SUMMARY

Craft CMS is a content management system (CMS). Versions 5.0.0-RC1 through 5.9.20, and 4.0.0-RC1 through 4.17.13 contain an authorization issue in the AssetsController::actionReplaceFile that can delete a source asset without source delete permission by supplying both assetId and sourceAssetId. AssetsController::actionReplaceFile() supports replacing a target asset file using another existing asset as the source. The action loads: assetId -> $assetToReplace and sourceAssetId -> $sourceAsset, then enforces replace permissions using ($assetToReplace ?: $sourceAsset). When both IDs are provided, this expression resolves to the target asset so no permission check is performed against the source asset volume. When both assets are present, Craft copies the source file into the target and then deletes the source asset. There is no deletion check for for the source asset. An authenticated user who can replace files in one volume can delete assets in another volume where they do not have delete permission, as long as they can obtain a sourceAssetId, leading to broken content references and data loss. This issue has been fixed in versions 4.17.14 and 5.9.21.

Published

Date2026-07-01

Updated

Date2026-07-01

RISK INFORMATION (Score: )

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-14440

SUMMARY

Description: To issue and renew TLS certificates on behalf of customers, Cloudflare's Universal SSL feature automatically manages the CAA RRset for the customer's zone. This auto-managed RRset is permissive by design (e.g. 'issue "letsencrypt.org"' without parameters). On Universal SSL zones, Cloudflare's authoritative DNS serves this auto-managed RRset at query time, superseding any customer-configured CAA records on the zone. When a customer publishes a stricter CAA record using the RFC 8657 accounturi or validationmethods parameters, the Certificate Authority does not observe those parameters when evaluating the served RRset under RFC 8659. As a result, the RFC 8657 account-binding and validation-method-binding protections are not enforced end-to-end on Universal SSL zones. Successful exploitation could result in issuance of a browser-trusted TLS certificate to an attacker, enabling MITM against the affected domain. Exploitation is non-trivial in practice: an attacker would need to hold an ACME account at one of the Certificate Authorities in the served CAA RRset and to simultaneously satisfy domain control validation across the multiple geographically distinct Network Perspectives the CA relies on for Multi-Perspective Issuance Corroboration. Cloudflare prefixes are anycast-announced from hundreds of locations globally, raising the bar against single-vantage-point BGP hijacks. Any resulting misissuance of a browser-trusted certificate is subject to Certificate Transparency logging required by major browsers, and would be visible to CT monitoring. Mitigation: Customers requiring strict RFC 8657 enforcement need to disable Universal SSL on the affected zone. Universal SSL's automatic CAA management and customer-set RFC 8657 accounturi and validationmethods enforcement are mutually exclusive by the nature of the issue, so there is no in-product workaround that preserves both. Certificate Transparency monitoring is recommended for all customers as a general detection control. Credits: David Osipov (ORCID: https://orcid.org/0009-0005-2713-9242), independent researcher

Published

Date2026-07-01

Updated

Date2026-07-01

RISK INFORMATION (Score: )

cvss4

Base Score: 7.6

Complexity: HIGH

CVSS:4.0/AV:A/AC:H/AT:P/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-14422

SUMMARY

Out of bounds read and write in Tint in Google Chrome prior to 150.0.7871.46 allowed a remote attacker to potentially perform out of bounds memory access via a crafted HTML page. (Chromium security severity: High)

Published

Date2026-07-01

Updated

Date2026-07-01

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…